Vendor, Atlanta, GA
Lymphatech, Inc.
UEI W7JWEZ412CR3, CAGE 78PR8
1 award and $4,100,000 obligated between September 12, 2024 and November 4, 2025, 100% under full and open competition, against 2.0 offers on average where reported. 7 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $4,100,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00018Definitive Contract, September 12, 2024, Full and Open Competition After Exclusion of Sources, 2 offersSolicitation | NIH NCINational Institutes of Health | ALL-IN-ONE Pressure, Flow Control, and Imaging for Culturing and Monitoring Lymphatic Microphysiologic SystemNAICS 541715, PSC AN13 | $4,100,000 |
- Places of performance
- Georgia
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 5 across 1 awards